Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?
Come December, as I observe my “pros-mitzvah” — 13 years on active surveillance (AS) for very low-risk prostate cancer — I feel I’m at a tipping point. Should I stay the course and keep monitoring my lesion — a single Gleason 6 of less than 1 mm seen back in 2010 and never again in […]